Literature DB >> 21875290

Epidemiologic status of bladder cancer in Shiraz, southern Iran.

Alireza Salehi1, Abdul-aziz Khezri, Leila Malekmakan, Alireza Aminsharifi.   

Abstract

BACKGROUND: Bladder cancer is the second most common malignancy of the genitourinary tract worldwide after prostate cancer. However, in Iran it is the most common cancer of the genitourinary system and the third most common cancer in males. The increasing trend in bladder cancer incidence in recent decades, along with the lack of research on this malignancy in Iran, make epidemiologic research important in light of its preventability through early recognition and limiting exposure to risk factors. The present study aimed to assess the epidemiology of bladder cancer in Shiraz, a large city in southern Iran, during a 2-year period.
METHODS: The data for this study were obtained from the population-based cancer registry of the Vice-Chancellery for Health Affairs of Shiraz University of Medical Sciences and Shiraz hospitals between March 1, 2007 and March 1, 2009. Demographic, clinical and pathological aspects of 216 patients with bladder cancer were investigated through careful review of their medical records. Statistical analyses were performed with SPSS software. P values less than 0.05 were considered statistically significant.
RESULTS: We analyzed data for 179 (82.9%) men and 37 (17.1%) women (mean age of 65.1∓12.7 years). Tobacco and opium use were found in 109 (65.3%) and 44 (34.1%) patients, respectively. Cigarette smokers and water pipe smokers were mostly men (P=0.001 and P=0.04, respectively). The most common type of tumor was transitional cell carcinoma (95.7%) and most tumors were of low malignant potential grade (39.7%). Nearly half of the patients suffered recurrence.
CONCLUSION: Comparisons with previous studies showed that bladder cancer tends to appear slightly more often in the elderly and that the tumors tend to have a higher grade of malignancy in our region. There is a need for more epidemiologic studies on the trends in the incidence and other epidemiologic indices.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875290

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

Review 1.  MicroRNAs as biomarkers associated with bladder cancer.

Authors:  Amene Homami; Farideh Ghazi
Journal:  Med J Islam Repub Iran       Date:  2016-12-29

Review 2.  Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer.

Authors:  Mahdi Afshari; Ghasem Janbabaei; Mohammad Amin Bahrami; Mahmood Moosazadeh
Journal:  PLoS One       Date:  2017-06-06       Impact factor: 3.240

Review 3.  A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.

Authors:  Bagher Farhood; Behzad Raei; Reza Malekzadeh; Maryam Shirvani; Masoud Najafi; Tohid Mortezazadeh
Journal:  Contemp Oncol (Pozn)       Date:  2019-04-05

4.  Survival rate of patients with bladder cancer and its related factors in Kurdistan Province (2013-2018): a population-based study.

Authors:  Mozhdeh Amiri; Sofimajidpour Heshmatollah; Nader Esmaeilnasab; Jamshid Khoubi; Ebrahim Ghaderi; Daem Roshani
Journal:  BMC Urol       Date:  2020-12-11       Impact factor: 2.264

5.  SIRT1 Gene Polymorphisms Are Associated with Urinary Bladder Cancer in an Iranian Population.

Authors:  Zahra Shafieian; Gholamreza Bahari; Mohammad Hashemi; Alireza Nakhaee
Journal:  Rep Biochem Mol Biol       Date:  2019-07

6.  Age distribution types of bladder cancers and their relationship with opium consumption and smoking.

Authors:  Arsalan Aliramaji; Aliakbar Kaseean; Yousef Reza Yousefnia Pasha; Hamid Shafi; Sekineh Kamali; Mohsen Safari; Emaduddin Moudi
Journal:  Caspian J Intern Med       Date:  2015

7.  Incidence Trend and Epidemiology of Common Cancers in the Center of Iran.

Authors:  Hosein Rafiemanesh; Narjes Rajaei-Behbahani; Yousef Khani; Sayedehafagh Hosseini; Zahra Pournamdar; Abdollah Mohammadian-Hafshejani; Shahin Soltani; Seyedeh Akram Hosseini; Salman Khazaei; Hamid Salehiniya
Journal:  Glob J Health Sci       Date:  2015-07-13

8.  Changing Epidemiology of Common Cancers in Southern Iran, 2007-2010: A Cross Sectional Study.

Authors:  Seyed Masoom Masoompour; Kamran B Lankarani; Behnam Honarvar; Seyed Hamidreza Tabatabaee; Mohsen Moghadami; Zahra Khosravizadegan
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

9.  Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran.

Authors:  Hamideh Rashidian; Kazem Zendehdel; Rajabali Daroudi; Mohammad Reza Ebadzadeh; Ali Akbar Haghdoost
Journal:  Iran J Public Health       Date:  2018-04       Impact factor: 1.429

10.  Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways.

Authors:  Mitsuho Imai-Sumida; Takeshi Chiyomaru; Shahana Majid; Sharanjot Saini; Hannah Nip; Rajvir Dahiya; Yuichiro Tanaka; Soichiro Yamamura
Journal:  Oncotarget       Date:  2017-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.